Smith & Nephew sees unchanged full year after flat Q1
Smith & Nephew said its full year outlook for underlying revenue growth remained unchanged in the 3%-4% range after posting flat first quarter revenue of $1.14bn, flat on a reported basis after -2% impact from the disposal of its gynaecology business and -1% currency headwind.
FTSE 100
8,320.76
16:59 27/09/24
FTSE 350
4,599.36
17:10 27/09/24
FTSE All-Share
4,555.44
17:04 27/09/24
Health Care Equipment & Services
11,214.84
17:10 27/09/24
Smith & Nephew
1,165.00p
16:44 27/09/24
Revenue was up 3% on an underlying basis for the period. Established markets, the US and other established markets revenue were all up 1%.
"In Europe we are making progress improving our execution, although the slight headwinds seen last year in some European countries continued,"Smith & Nephew said.
"Performance in the emerging markets was good, returning to double-digit growth, with China growing 14% in the quarter."
"On a reported basis, we expect 2017 revenue growth to be in the range of 1.6%-2.6% based on prevailing exchange rates at the end of April and reflecting the 80bps headwind from the disposal of the gynaecology business," the company said.